EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Nuclear dysfunction in aging and neurodegeneration

Abbigael Aday, Jack Tiller, Adarsh Melukote, Zachary C Walton, Anna King, Luke Castillo, Rakez Kayed, Mauro Montalbano iD

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Abbigael Aday und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Aging, Cell Nucleus. Die Arbeit nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are characterized by a loss of neuronal function and structure, often in a region‐specific manner. Multiple factors contribute to neuronal dysfunction and death, including pathogenic protein buildup, protein mislocalization, and inflammation. Despite extensive research, the common mechanisms driving neurodegeneration remain incompletely understood, partly because pathological processes affect interconnected cellular components such as the cytosol, cytoskeleton, and nucleus. Emerging evidence indicates that changes in nuclear structure and function are not simply secondary to cellular stress but play key roles in aging and neurodegenerative disease progression. This review explores important aspects of nuclear dysfunction, including alterations in nuclear architecture, chromatin organization, nucleocytoplasmic transport, DNA damage responses, and inflammatory signaling. It further discusses how these processes converge to increase neuronal vulnerability and may extend beyond normal aging to promote neurodegeneration. Overall, this review highlights nuclear dysfunction as a significant factor in neuronal impairment and underscores the need for therapies targeting nuclear integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAgingCell NucleusHumansAnimalsDNA DamageNeurons

Stichwörter der Autor:innen

agingdementianeurodegenerationnuclear dysfunctionnucleocytoplasmic transportprotein aggregation

Autor:innen und Institutionen

  • Department of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
  • MD-PhD Program, University of Texas Medical Branch, Galveston, Texas, USA.
  • Mitchell Center for Neurodegenerative Disorders, University of Texas Medical Branch, Galveston, Texas, USA.
  • School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.

ORCID-Profile: Mauro Montalbano

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Aday, A., Tiller, J., Melukote, A., Walton, Z. C., King, A., Castillo, L., Kayed, R., & Montalbano, M. (2026). Nuclear dysfunction in aging and neurodegeneration. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71657

Vancouver

Aday A, Tiller J, Melukote A, Walton ZC, King A, Castillo L, et al. Nuclear dysfunction in aging and neurodegeneration. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71657

BibTeX
@article{Aday2026,
  author = {Aday, Abbigael and Tiller, Jack and Melukote, Adarsh and Walton, Zachary C and King, Anna and Castillo, Luke and Kayed, Rakez and Montalbano, Mauro},
  title = {Nuclear dysfunction in aging and neurodegeneration},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71657}
}
Kostenlos starten →